Pharmaceutical Technology

MAY 26, 2023

Pharma company merger and acquisition (M&A) activity in the first half of 2023 has remained relatively low, consistent with the second half of last year, but investors predict deals will increase later in 2023. Experts at PWC, Goldman Sachs, and Morgan Stanley agree that pharma-related M&A is expected to pick up in 2023.

Life Science 130

Life Science Manufacturing Contract Manufacturing Gene Therapy 130

Drug Discovery World

DECEMBER 6, 2023

The industry has responded that these sales rebate levels have damaged the UK’s international standing with global life science companies and are likely to continue to negatively impact UK life sciences and NHS patients’ access to medicines. in Spain and 8.25% in Ireland.

Life Science 59

Life Science Branding Medicine Pharma Companies 59

pharmaphorum

MAY 18, 2021

Pre-commercial & Emerging pharma companies may not think they have the resources to match the launch strategies of big pharma. He takes us through the challenges of a successful launch and explains what pre-commercial companies need to focus on to hit their goals. Building strong data foundations. ” says Hale.

Production 52

Production Sales Life Science Marketing 52

Pharmaceutical Technology

JULY 26, 2022

Following the merger, NewAmsterdam Pharma CEO Dr Michael Davidson will lead the newly formed holding company, which is expected to be named NewAmsterdam Pharma Company. In January last year, NewAmsterdam Pharma raised $196m in a Series A funding round to support the full Phase III development of obicetrapib.

Life Science 147

Life Science Trials Pharma Companies Production 147

pharmaphorum

AUGUST 18, 2020

Pharma companies have improved how they engage with healthcare providers as a result of COVID-19, according to a new survey of HCPs. This has resulted in pharma companies being more relevant and providing more value in closing the care gap, the report says.

Pharma Companies 130

Pharma Companies Sales Life Science Marketing 130

pharmaphorum

NOVEMBER 8, 2022

Ask nearly any pharma company these days if they’re patient-centric, and you’ll probably get an answer in the affirmative. Suchotliff sat down with Deep Dive to discuss the current state of patient centricity in pharma, some of the common foibles and misconceptions, and how pharma companies can get themselves on the right track. “I

Life Science 52

Life Science Pharma Companies Branding Development 52

Drug Discovery World

OCTOBER 9, 2023

Over twenty pharma companies have rejected the UK government’s proposed changes to the statutory scheme for branded medicines, the latest move in an ongoing disagreement between the government and industry. And will be “highly damaging to UK life sciences and NHS patients’ access to medicines”.

Medicine 52

Medicine Life Science Branding Pharma Companies 52

Drug Discovery World

MAY 6, 2024

Thanks to a prestigious academic legacy, Europe has long been a dominant region for life sciences. Europe is traditionally a life sciences powerhouse, with a strong tradition in pharmaceutical discovery. The oldest, still active pharmaceutical company worldwide, Merck, started life in 1668 in Darmstadt, Germany.

Drugs 59

Drugs Life Science Gene Editing Gene 59

pharmaphorum

OCTOBER 19, 2022

Emma Hyland, VP strategy, commercial content at Veeva Systems, tells us modular content is the most significant wave of innovation hitting the content world in life sciences, and rightly so because HCPs’ needs and expectations have changed. “There isn’t a one-size-fits-all for how the life sciences industry creates content.

Life Science 89

Life Science Compliance Production Pharma Companies 89

Drug Discovery World

FEBRUARY 10, 2023

Though not without its challenges, the life sciences industry in Scandinavia is well represented and acts as a serious contender for R&D output. More so, the Karolinska Institute is ranked at number seven in the world for the subjects of life sciences and medicine.

Life Science 52

Life Science Drugs Gene Therapy Manufacturing 52

pharmaphorum

JANUARY 19, 2021

A new survey highlights the importance of customer reference data to digital transformation and analyses ways pharma companies can improve the quality of their datasets. More pharma companies are moving in this direction, and 78% of respondents said they are undertaking, or planning, a customer data enhancement initiative.

Sales 85

Sales Pharma Companies Life Science Production 85

pharmaphorum

NOVEMBER 30, 2022

Veeva Systems invited pharmaphorum to attend its industry summit in Madrid this week, a huge event that gathered together over 1,000 individuals from life sciences and pharma. The question is, how can the journey there be accelerated, when on the horizon awaits a life sciences future very much immersed in speciality medicine?

Life Science 97

Life Science Pharma Companies Sales Marketing 97

pharmaphorum

NOVEMBER 3, 2021

Pharma companies are producing and distributing more digital content than ever due to the pandemic, meaning the content presented needs to stand out in the crowded digital space to garner attention. Content metrics is the collection of data related to an industry or a company’s content. Read the full Veeva Systems report.

Pharma Companies 93

Pharma Companies Life Science Marketing Branding 93

pharmaphorum

MAY 13, 2021

Virtual communications between sales reps and HCPs jumped significantly during 2020, making it more important than ever for pharma companies to maintain up-to-date customer data. Rather than simply surviving, the life sciences industry needs to respond proactively. About Veeva Systems.

Life Science 88

Life Science Sales Pharma Companies Production 88

pharmaphorum

JUNE 10, 2022

If you work in pharma, the chances are you’re no stranger to the United States Food and Drug Administration, or FDA, which regulates pharmaceuticals. A device means a product that’s used in the diagnosis of disease and intended to affect the structure and function of the body of humans,” Faget said.

Regulation 133

Regulation Production Life Science Drugs 133

Pharmaceutical Technology

OCTOBER 28, 2022

According to Alex Edwards, solutions architect at leading pharmaceutical translations provider RWS: “Pharma companies have three years until EU-CTR is mandatory, but it's in everyone's interest to start sooner rather than later. A key part of this includes the careful selection of personnel for the lay summary production.

Clinical Trials 130

Clinical Trials Clinical Trials Life Science Trials 130

pharmaphorum

DECEMBER 7, 2021

Since the onset of the Covid-19 pandemic, life science companies have acted quickly to address the evolving digital needs of healthcare professionals, with mixed success (see graph 1). For the most part, life science companies have a relatively good knowledge of what their audiences want and need from them.

Life Science 102

Life Science Pharma Companies Branding Marketing 102

pharmaphorum

DECEMBER 16, 2020

Experts from Healthware Group explore how companies can rebuild their approach to digital from the ground up for the benefit of patients. Digital is not just a nice-to-have for pharma companies – it’s a necessity for ensuring that patients have the best possible outcomes in modern healthcare systems.

Life Science 59

Life Science Pharma Companies Sales Medicine 59

pharmaphorum

JANUARY 25, 2022

The Toronto-based company already counts many of the world’s largest pharma companies among its customers, using its platform for a range of tasks such as improving reagent and antibody selection to help scientists run more successful experiments, drawing on data from published studies and organisations’ internal databases.

Life Science 52

Life Science Pharma Companies Reagent Scientist 52

pharmaphorum

JANUARY 16, 2023

Two top pharma companies have exited the UK’s voluntary medicines pricing agreement in protest at what the industry has said is a “punitive” system of revenue clawbacks, casting doubt on the future of the scheme in its present form.

Life Science 69

Life Science Drugs Branding Medicine 69

pharmaphorum

MAY 12, 2022

German drugmaker Boehringer Ingelheim has sold an artificial intelligence-powered software platform it developed to monitor drug safety data to ArisGlobal, which provides cloud software to life sciences companies. ” The post Boehringer sells drug safety software to ArisGlobal appeared first on.

Drugs 52

Drugs Life Science Pharma Companies Development 52

pharmaphorum

JANUARY 31, 2022

Creating personalised, compliant content is becoming increasingly important for life science companies as HCPs demand more from their digital content. Pharma companies created 3.5 Veeva is the global leader in cloud software for the life sciences industry. Download the whitepaper here: [link].

Marketing 52

Marketing Life Science Compliance Pharma Companies 52

Drug Discovery World

DECEMBER 14, 2023

The new hub will become a part of the already thriving life sciences sector in the Glasgow area, most of which is centred around the university, the Cancer Research UK Scotland Institute and the BioCity cluster, making Glasgow and its surrounds one of the most important regions for drug discovery and development in the UK.

Drugs 75

Drugs Life Science Research Scientist 75

pharmaphorum

DECEMBER 23, 2020

Verily is planning “significant and focused growth” in 2021 after closing a $700 million funding round from investors including its parent company, and Google holding firm, Alphabet. Meanwhile, the last 12 months have seen a refocusing at Onduo.

Life Science 59

Life Science Pharma Companies Clinical Research Production 59

pharmaphorum

JUNE 9, 2021

At Fishawack Health, we are always seeking opportunities to enhance our capabilities and help our life science clients navigate the new, dynamically changing healthcare environment. Meet closerlook. Meet closerlook.

Marketing 56

Marketing Life Science Branding Production 56

pharmaphorum

NOVEMBER 15, 2022

On 14th November, investors and life science & healthcare executives descended on London’s famed Old Billingsgate building to attend LSX’s Inv€$tival Showcase, part of Europe’s biggest dedicated healthcare investment week. Investing in the future of the European life sciences. For Müllenbeck, this is an opportunity.

Life Science 84

Life Science Pharma Companies Marketing Production 84

XTalks

OCTOBER 4, 2023

This evidence is indispensable in garnering support from healthcare stakeholders and payers who must evaluate whether products offer value for money within constrained healthcare budgets. What types of product portfolios do you oversee now and have overlooked previously?

Marketing 105

Marketing Development Drugs Gene Therapy 105

pharmaphorum

JANUARY 29, 2021

The future of life sciences CRM will be defined by rapid digital transformation and a focus on customer experience – and those who stick to old ways of working will be left in the dust, according to new research from Gartner. From CRM to CXM.

Life Science 126

Life Science Sales Marketing Pharma Companies 126

XTalks

MAY 6, 2022

They discussed current challenges and solutions that life science companies and clinical development organizations have with the management of clinical data. To produce ethical results in a timely manner, life science companies should ensure that they have a robust and reliable clinical data pipeline in place.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Life Science 98

pharmaphorum

NOVEMBER 23, 2022

A director in life sciences consulting for EY, she works within the commercial space for such companies, as well as their clients. “My We have built a product that is universal, that can really bring any pharma party, any payers in any market to really work together. Innovative offerings around market access.

Life Science 98

Life Science Marketing Medicine Production 98

Drug Discovery World

OCTOBER 16, 2023

Despite the overall reduction in major pharma R&D centres in the UK, global pharma companies continue to engage with academic and biotech organisations here, particularly in hotspots such as the Golden Triangle, the Northwest, and Scotland, through the strong networks that have been developed between these organisations.

Drugs 75

Drugs Life Science Gene Therapy Genome 75

pharmaphorum

FEBRUARY 17, 2021

Armed with these insights, life sciences companies can develop patient-centric solutions that will lead to more successful products. Importantly, you can ensure product and service messages are relevant to patients and add value, driving competitive advantage in increasingly crowded landscapes.

Life Science 97

Life Science Branding Genetics Trials 97

pharmaphorum

MARCH 2, 2022

There is a growing pipeline of psychedelic therapies and an expanding body of science to suggest that they may be able to provide an alternative to existing mental health treatments. The latter compound has already been approved for treatment-resistance depression as the product Spravato (esketamine), after being developed by Janssen.

Life Science 102

Life Science Clinical Trials Clinical Trials Trials 102

pharmaphorum

SEPTEMBER 15, 2020

For pharma companies, COVID-19 has proved that they can be agile and responsive to rapidly evolving market conditions, as evidenced by the way they have adjusted to a new global paradigm while successfully continuing operations. Preparing for an agile pharma future. Jeremy Richter, Tag. Build on the rapid responses to COVID-19.

Branding 114

Branding Marketing Pharma Companies Life Science 114

XTalks

JULY 16, 2021

The company said that while benzene is not an ingredient in any of its sunscreen products, it was detected during routine internal testing in some samples of its aerosol sunscreen finished products. Therefore, levels should be monitored at different stages of production to avoid harmful benzene contamination.

Contamination 105

Contamination Production Drugs Branding 105

XTalks

DECEMBER 22, 2021

If the past year is anything to go by, then 2022 will also be a year marked by continued innovations in the life sciences. Here is a look at some life science trends to expect in the coming year, including key themes and topics in the pharmaceutical, biotechnology and medical device industries to keep an eye out for in 2022.

Life Science 98

Life Science RNA Vaccination Vaccine 98

XTalks

FEBRUARY 9, 2022

Findings from an analysis conducted by Constella Intelligence , a digital risk protection company, show widespread cybersecurity vulnerabilities that are costing pharma companies significantly. The report includes information on breaches, exposures and leaks in the pharma sphere. Pharma Cybersecurity and Cyber Attacks.

Pharma Companies 98

Pharma Companies Insulin Packaging Packaging 98